JAFFER A AJANI to Proto-Oncogene Proteins c-akt
This is a "connection" page, showing publications JAFFER A AJANI has written about Proto-Oncogene Proteins c-akt.
Connection Strength
0.163
-
A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer. Eur J Cancer. 2019 02; 108:17-24.
Score: 0.098
-
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. J Clin Oncol. 2009 Feb 20; 27(6):857-71.
Score: 0.049
-
The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 2012 Mar 20; 21(3):374-87.
Score: 0.015